Company Filing History:
2 out of 312 
1 out of 1 Years Active: 1989-1994
Title: **Massimo Pomponi: Innovator in Acetylcholinesterase Inhibition**
Introduction
Massimo Pomponi is a distinguished inventor based in Rome, Italy, known for his contributions to the field of pharmaceuticals. With a total of three patents to his name, Pomponi has been focusing his research on innovative compounds that exhibit acetylcholinesterase inhibition properties, essential for various therapeutic applications.
Latest Patents
Among his latest innovations, Pomponi has developed two significant patents. The first one details "Physostigmine derivatives with acetylcholinesterase inhibition," which consists of compounds of a general formula, where R can be a linear alkyl chain comprising from 2 to 20 carbon atoms, or other molecular structures when R' is H. The second patent involves "Organic salts of physostigmine derivatives," which outlines the preparation of these compounds for pharmaceutical use. In this case, R can represent both linear and branched alkyl groups or cycloalkyl and aryls.
Career Highlights
Massimo Pomponi has made impactful strides in his career, having worked at notable institutions such as the National Research Council (Consiglio Nazionale Delle Ricerche) and Mediolanum Farmaceutici S.r.l. His innovations in chemistry and pharmaceutical science have substantially contributed to the advancement of treatment options for conditions requiring acetylcholinesterase inhibition.
Collaborations
Throughout his career, Pomponi has had the opportunity to collaborate with esteemed colleagues in the field, including Mario Brufani and Maurizio Marta. These partnerships have not only enriched his research but also enhanced the scope and application of his patented inventions.
Conclusion
Massimo Pomponi's work exemplifies the spirit of innovation in pharmaceuticals, particularly in the realm of acetylcholinesterase inhibitors. His patents hold promising potential for further developments in medical applications, solidifying his role as a key figure in contemporary pharmacological research.